Position
BRAIDWELL LP in Krystal Biotech, Inc.
Back to the book · All holders of KRYS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.15M$246.54 → $258.32
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 202.1K | $49.8M | — | — | — | 1.6% |
| Q1 2026 | 182.4K | $47.1M | $258.32 | $2.15M | −$4.85M | 1.6% |